FDA — authorised 20 May 2008
- Application: NDA021775
- Marketing authorisation holder: CUBIST PHARMS
- Local brand name: ENTEREG
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Alvimopam in United States
FDA authorised Alvimopam on 20 May 2008
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Alvimopam approved in United States?
Yes. FDA authorised it on 20 May 2008.
Who is the marketing authorisation holder for Alvimopam in United States?
CUBIST PHARMS holds the US marketing authorisation.